CD8A and melanoma: In human clinical trials on malignant melanoma patients, DNA vaccines encoding xenogeneic melanosomal antigens (tyrosinase, gp100) induced CD8( +) T-cell responses [39] and epitope spreading of CD8 + T-cell response was observed [40].